Related Experiment Video
Updated: Apr 24, 2026

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
Investigating the molecular basis of Siah1 and Siah2 E3 ubiquitin ligase substrate specificity
Anupriya Gopalsamy1, Thilo Hagen2, Kunchithapadam Swaminathan3
1Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Abstract:
The Siah1 and Siah2 E3 ubiquitin ligases play an important role in diverse signaling pathways and have been shown to be deregulated in cancer. The human Siah1 and Siah2 isoforms share high sequence similarity but possess contrary roles in cancer, with Siah1 more often acting as a tumor suppressor while Siah2 functions as a proto-oncogene. The different function of Siah1 and Siah2 in cancer is likely due to the ubiquitination of distinct substrates. Hence, we decided to investigate the molecular basis of the substrate specificity, utilizing the well-characterized Siah2 substrate PHD3. Using chimeric and mutational approaches, we identified critical residues in Siah2 that promote substrate specificity. Thus, we have found that four residues in the N-terminal region of the Siah2 substrate binding domain (SBD) (Ser132, His150, Pro155, Tyr163) are critical for substrate specificity. In the C-terminal region of the SBD, a single residue, Leu250, was identified to promote the specific binding of Siah2 SBD to PHD3. Our study may help to overcome the challenges in the identification of Siah2 specific inhibitors.
Insights
Siah1 and Siah2 E3 ubiquitin ligases have opposing roles in cancer. Researchers identified key residues in Siah2 responsible for its specific substrate binding, potentially aiding in inhibitor development.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Siah1 and Siah2 are E3 ubiquitin ligases involved in cell signaling and cancer.
- Siah1 and Siah2 have contrasting roles in cancer: Siah1 as a tumor suppressor and Siah2 as a proto-oncogene.
- Substrate specificity is key to understanding the differential functions of Siah1 and Siah2.
Purpose of the Study:
- To investigate the molecular basis of substrate specificity for Siah2.
- To identify critical residues in Siah2 that determine its binding to specific substrates like PHD3.
- To provide insights for the development of Siah2-specific inhibitors.
Main Methods:
- Utilized chimeric and mutational approaches to analyze Siah2.
- Focused on the substrate binding domain (SBD) of Siah2.
- Investigated the interaction between Siah2 SBD and its substrate PHD3.
Main Results:
- Identified four critical residues (Ser132, His150, Pro155, Tyr163) in the N-terminal region of Siah2 SBD for substrate specificity.
- Identified a single residue (Leu250) in the C-terminal region of Siah2 SBD crucial for specific binding to PHD3.
- Demonstrated specific residues dictating Siah2 substrate binding.
Conclusions:
- Specific amino acid residues in Siah2's substrate binding domain dictate its substrate specificity.
- Understanding these residues is crucial for differentiating Siah1 and Siah2 functions in cancer.
- Findings may facilitate the design of targeted Siah2 inhibitors to overcome challenges in cancer therapy.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Ligand Binding and Linkage

